Gamma-Selective Retinoid Agonist (TESRA)

· Hoffmann-La Roche

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Gamma-Selective Retinoid Agonist (TESRA), covering 2016-11-02 to 2016-11-02. Get the full timeline:

Most recent: Clinical Trial Update: TESRA: (Treatment of Emphysema With a Gamma-Selective Retinoid Agonist) [Phase 2]